Press Releases for MDS

Press Releases
MDS Announces Voting Support Agreements
11 Midas Shops in San Diego Area Add SpeeDee Oil Change Services
Midas Reports Second Quarter Earnings of $0.03 Per Diluted Share after $0.09 of Non-Cash Special Items; 11 Percent Increase in Traffic at U.S. Midas Shops Offset by Decline in Average Ticket; SpeeDee Co-Brand Test Shops Post 17 Percent Sales Increase
MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production
MDS Nordion Continues to Urge Government of Canada to Complete MAPLE Project to Address Critical Medical Isotope Shortage
MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations
MDS Nordion Collaborates With Karpov Institute of Physical Chemistry to Develop Molybdenum-99 for Global Nuclear Medicine Market
Midas Reaches out to Displaced Service Customers, Dealers and Employees of Closing Auto Dealerships
MDS Nordion Begins to Manufacture Cardiac Imaging Agent
MDS Pharma Services Expands Drug Discovery Capability in Asia
MDS to Release Second-Quarter 2009 Financial Results
MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage
Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety
Applied Biosystems/MDS Analytical Technologies Accelerates Productivity for Drug Development and Clinical Research With New Mass Spectrometry Solution
MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
Midas Reports First Quarter Earnings of $0.07 Per Diluted Share; Six Percent Growth in U.S. Midas Shop Traffic Offset by Lower Average Ticket; SpeeDee Co-Brand Test Shops Post 15 Percent Sales Increase
Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometer to Accelerate Proteomics Research
Midas Delays Filing Annual Report on Form 10-K; Additional Pension Expenses Will Affect 2006 -- 2008 Results; 2008 Earnings Per Diluted Share Revised to $0.56 From $0.57
Midas Delays Filing Annual Report on Form 10-K; Additional Pension Expenses Will Affect 2006 – 2008 Results; 2008 Earnings Per Diluted Share Revised to $0.56 from $0.57
Midas Delays Filing Annual Report on Form 10-K; Additional Pension Expenses Will Affect 2006 - 2008 Results; 2008 Earnings Per Diluted Share Revised to $0.56 From $0.57
MDS Announces Renewal of Company's Shareholders Rights Plan
Applied Biosystems/MDS Analytical Technologies AB SCIEX QTRAP 5500 Mass Spectrometry System Earns Scientists’ Choice Award from SelectScience
MDS Reports First Quarter 2009 Financial Results - PR Newswire
MDS Reports First Quarter 2009 Financial Results - CNW
Applied Biosystems/MDS Analytical Technologies Launch New Test Methods to Simplify Mass Spectrometry Applications
MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians
Midas Reports 2008 Earnings Per Diluted Share of $0.57; Cash Flow from Operating Activities Remains Strong at $1.90 Per Share; SpeeDee Co-Brand Test Shops Continue to Produce Significant Sales Increases
MDS to Release First-Quarter 2009 Financial Results
MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food
MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food
MDS Analytical Technologies' Laser Capture Microdissection Helps Facilitate Discovery of Potential New Colon-Cancer Biomarker
MDS Announces Formation of Special Committee
MDS Files 2008 Annual Reports
MDS Files 2008 Annual Reports
MDS Reports Final Fourth-Quarter 2008 Results
MDS Reports Final Fourth-Quarter 2008 Results
MDS Pharma Services Names Rudy Howard Chief Financial Officer
MDS Pharma Services Names Rudy Howard Chief Financial Officer
MDS Reports Preliminary Fourth Quarter 2008 Results
MDS Reports Preliminary Fourth Quarter 2008 Results
MDS Provides Update on Fiscal 2008 Performance
MDS Provides Update on Fiscal 2008 Performance
MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
Midas Will Present at Gabelli Conference
Obrem Capital Management Issues Letter to MDS Management and Board of Directors
Midas Reports Third Quarter Earnings of $0.12 Per Diluted Share after $0.04 of Special Items; Strong Start for Co-Branded SpeeDee-Midas Shops in Central California
MDS Analytical Technologies Announces Availability of New High-Throughput Method to Detect Melamine in Food
MDS Analytical Technologies Announces Availability of New High-Throughput Method to Detect Melamine in Food
MDS Pharma Services Wins Two Good Clinical Practice Journal Awards
MDS Pharma Services Wins Two Good Clinical Practice Journal Awards
MDS Pharma Services Upgrades, Expands Singapore Global Central Laboratory Operation - PR Newswire
MDS Pharma Services Upgrades, Expands Singapore Global Central Laboratory Operation - CNW
Gabelli & Company's 32nd Annual Automotive Aftermarket Symposium
Applied Biosystems/MDS Analytical Technologies Introduces Next-Generation Mass Spectrometry Systems
Midas to Present at CL King Conference; Reports Continuing Softness in Retail Sales; First Midas-SpeeDee Co-Branded Test Stores Exceeding Expectations
MDS to present at UBS 2008 Global Life Sciences Conference
MDS to present at UBS 2008 Global Life Sciences Conference
MDS Reports Third Quarter 2008 Financial Results
MDS Reports Third Quarter 2008 Financial Results
MDS Pharma Services Strengthens Medical Leadership in Phase IIa Clinical Research
MDS to Release Third Quarter 2008 Results
MDS Pharma Services Strengthens Medical Leadership in Phase IIa Clinical Research
MDS to Release Third Quarter 2008 Results
Midas Reports Second Quarter Earnings of $0.16 Per Diluted Share after $0.03 of Special Items; Begins Co-Branding of Midas Services at SpeeDee Shops
CRi's Nuance(TM) Multispectral Imaging System Now Compatible with MDS Analytical Technologies' MetaMorph(R) Image Acquisition Software
MDS To Record Restructuring Charge
MDS To Record Restructuring Charge
MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
MDS Pharma Services Launches Next Generation Phase I Study Management System
MDS Pharma Services Launches Next Generation Phase I Study Management System
MDS Inc. Announces Normal Course Issuer Bid
MDS Inc. Announces Normal Course Issuer Bid
MDS Analytical Technologies Acquires Blueshift Biotechnologies
MDS Analytical Technologies Acquires Blueshift Biotechnologies
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team - PR Newswire
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team - CNW
MDS Pharma Services Hires Biomarkers Thought Leader
MDS Pharma Services Hires Biomarkers Thought Leader
MDS to Present at Jefferies 2nd Annual Healthcare Conference
MDS to Present at Jefferies 2nd Annual Healthcare Conference
Hon. George W. Adams to Mediate in Midas Franchisee Lawsuit
MDS Pharma Services Adopts SAS(R) Technology for Clinical Trial Data Warehousing and Analysis
MDS Pharma Services Adopts SAS(R) Technology for Clinical Trial Data Warehousing and Analysis
MDS Reports Second Quarter 2008 Results - Jun 5 2008 7:08AM
MDS Reports Second Quarter 2008 Results - Jun 5 2008 7:08AM
MDS Reports Second Quarter 2008 Results - Jun 5 2008 7:08AM
MDS Reports Second Quarter 2008 Results - Jun 5 2008 7:16AM
Scientific Collaboration Seeks to Develop New Methods to Better Identify Contaminants in Drinking Water
Applied Biosystems/MDS Analytical Technologies and PREMIER Biosoft Collaborate to Deliver Glycomics Research Solutions
MDS Pharma Services Adopts Innovative Technology for Bioanalysis
Applied Biosystems/MDS Analytical Technologies Advance Proteomics Research Through Suite of Integrated Mass Spectrometry Solutions
MDS to Release Second Quarter 2008 Results - PR Newswire - May 29 2008 8:08AM
MDS to Release Second Quarter 2008 Results - PR Newswire - Jun 1 2008 4:30AM
MDS to Release Second Quarter 2008 Results - CNW
Applied Biosystems/MDS Analytical Technologies' Software Expands Detection of Chemical Contaminants in Food and Water